Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 6.84 as of 2026-09-12T00:16:14.031Z.
Consensus retrieved: 2026-09-10T03:59:53.692Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-12T00:16:14.031Z.
Quote observation: 2026-09-11T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 13132ea4981c9643e6849d95bb5bdea69b28c3dc5103a2632f2e599c1ff33a06
Forward PE Ratio (6.84) = Dated Quote Price ($10.46) / Consensus Forward EPS ($1.53)
FORWARD PE RATIO
6.84
SECTOR MEDIAN · HEALTHCARE
18.95
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-63.91%
vs the sector median at left
DENTSPLY SIRONA Inc.
Market Cap
$2.10B
Forward PE Ratio
6.84
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.10B | 6.84 |
| TransMedics Group, Inc. (TMDX)vs › | $2.84B | 55.39 |
| Teladoc Health, Inc. (TDOC)vs › | $1.12B | N/A |
| NRC Health (NRC)vs › | $475.98M | 24.00 |
| Shoulder Innovations, Inc. (SI)vs › | $384.28M | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $16.49M | N/A |
| Doximity, Inc. (DOCS)vs › | $4.78B | 19.01 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.16B | 20.07 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.14B | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.64B | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
6.8
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $10.46, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.53 | $1.47 – $1.57 | 10 | 6.8x |
| 2027-12-31 | $1.52 | $1.46 – $1.56 | 12 | 6.9x |
| 2028-12-31 | $1.68 | $0.24 – $3.77 | 8 | 6.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
